These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8905739)

  • 1. A C-terminal cyclic 8-13 neurotensin fragment analog appears less exposed to neprilysin when it crosses the blood-brain barrier than the cerebrospinal fluid-brain barrier in mice.
    Van Kemmel FM; Dubuc I; Bourdel E; Fehrentz JA; Martinez J; Costentin J
    Neurosci Lett; 1996 Oct; 217(1):58-60. PubMed ID: 8905739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Centrally administered [D-Trp11]neurotensin, as well as neurotensin protected from inactivation by thiorphan, modifies locomotion in rats in a biphasic manner.
    Nouel D; Dubuc I; Kitabgi P; Costentin J
    Peptides; 1990; 11(3):551-5. PubMed ID: 2381875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of delta opioid receptors in the effects of inhibitors of enkephalin-degrading peptidases on the horizontal and vertical components of locomotion in mice.
    Michael-Titus A; Dourmap N; Costentin J; Schwartz JC
    Neuropeptides; 1990 Feb; 15(2):89-100. PubMed ID: 1981928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naloxone-insensitive potentiation of neurotensin hypothermic effect by the enkephalinase inhibitor thiorphan.
    Coquerel A; Dubuc I; Menard JF; Kitabgi P; Costentin J
    Brain Res; 1986 Nov; 398(2):386-9. PubMed ID: 3542125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic inhibition of enkephalinase induces changes in the antinociceptive and locomotor effects of the enkephalinase inhibitor acetorphan in rats.
    Bousselmame R; Eustache M; Michael-Titus A; Costentin J
    Neuropharmacology; 1991 Aug; 30(8):865-70. PubMed ID: 1780043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypothermic effect of neuromedin N in mice and its potentiation by peptidase inhibitors.
    Dubuc I; Nouel D; Coquerel A; Menard JF; Kitabgi P; Costentin J
    Eur J Pharmacol; 1988 Jun; 151(1):117-21. PubMed ID: 3416919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of apomorphine-induced yawning and penile erection by neurotensin.
    Nouel D; Costentin J
    Peptides; 1991; 12(4):755-9. PubMed ID: 1788138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral excitatory effects of two enkephalinase inhibitors, acetorphan and thiorphan, and an enkephalin analogue, [D-Ala2-Met5]-enkephalinamide, on uterine motility in periparturient rats in vivo and in vitro.
    Adjroud O
    J Reprod Fertil; 1995 Jul; 104(2):181-6. PubMed ID: 7473405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of enkephalinase inhibition in the living mouse, using [3H]acetorphan as a probe.
    De la Baume S; Brion F; Dam Trung Tuong M; Schwartz JC
    J Pharmacol Exp Ther; 1988 Nov; 247(2):653-60. PubMed ID: 3183961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiorphan and acetorphan inhibit gastric secretion by a central, non-opioid mechanism in the rat.
    Chicau-Chovet M; Dubrasquet M; Chariot J; Tsocas A; Lecomte JM; Rozé C
    Eur J Pharmacol; 1988 Sep; 154(3):247-54. PubMed ID: 3234479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological effects of c(Lys-Lys-Pro-Tyr-Ile-Leu-Lys-Lys-Pro-Tyr-Ile-Leu) (JMV2012), a new analogue of neurotensin that crosses the blood-brain barrier.
    Bredeloux P; Cavelier F; Dubuc I; Vivet B; Costentin J; Martinez J
    J Med Chem; 2008 Mar; 51(6):1610-6. PubMed ID: 18321036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo 'enkephalinase' inhibition by acetorphan in human plasma and CSF.
    Spillantini MG; Geppetti P; Fanciullacci M; Michelacci S; Lecomte JM; Sicuteri F
    Eur J Pharmacol; 1986 Jun; 125(1):147-50. PubMed ID: 3015640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analgesic potency of S-acetylthiorphan after intravenous administration to mice.
    Lambert DM; Mergen F; Poupaert JH; Dumont P
    Eur J Pharmacol; 1993 Oct; 243(2):129-34. PubMed ID: 8276061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and pharmacological properties of 2-[S-acetylthiorphan]-1,3- diacylaminopropan-2-ol derivatives as chimeric lipid drug carriers containing an enkephalinase inhibitor.
    Lambert DM; Mergen F; Berens CF; Poupaert JH; Dumont P
    Pharm Res; 1995 Feb; 12(2):187-91. PubMed ID: 7784331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thiorphan-induced neprilysin inhibition raises amyloid beta levels in rabbit cortex and cerebrospinal fluid.
    Newell AJ; Sue LI; Scott S; Rauschkolb PK; Walker DG; Potter PE; Beach TG
    Neurosci Lett; 2003 Oct; 350(3):178-80. PubMed ID: 14550923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of thiorphan, bestatin and a novel metallopeptidase inhibitor JMV 390-1 on the recovery of neurotensin and neuromedin N released from mouse hypothalamus.
    Kitabgi P; Dubuc I; Nouel D; Costentin J; Cuber JC; Fulcrand H; Doulut S; Rodriguez M; Martinez J
    Neurosci Lett; 1992 Aug; 142(2):200-4. PubMed ID: 1454216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmented analgesic effects of enkephalinase inhibitors combined with transcranial electrostimulation.
    Malin DH; Lake JR; Hamilton RF; Skolnick MH
    Life Sci; 1989; 44(19):1371-6. PubMed ID: 2716474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective tolerance to the hypothermic and anticataleptic effects of a neurotensin analog that crosses the blood-brain barrier.
    Boules M; McMahon B; Wang R; Warrington L; Stewart J; Yerbury S; Fauq A; McCormick D; Richelson E
    Brain Res; 2003 Oct; 987(1):39-48. PubMed ID: 14499944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological properties of acetorphan, a parenterally active "enkephalinase" inhibitor.
    Lecomte JM; Costentin J; Vlaiculescu A; Chaillet P; Marcais-Collado H; Llorens-Cortes C; Leboyer M; Schwartz JC
    J Pharmacol Exp Ther; 1986 Jun; 237(3):937-44. PubMed ID: 3519939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of chronic infusion of neurotensin and a neurotensin NT1 selective analogue PD149163 on amphetamine-induced hyperlocomotion.
    Norman C; Beckett SR; Spicer CH; Ashton D; Langlois X; Bennett GW
    J Psychopharmacol; 2008 May; 22(3):300-7. PubMed ID: 18208905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.